1. 27 Jan 2025

   Funding round

   €22.7M

   Cumulative €22.7M

Amounts in EUR, converted at the ECB rate on the event date. Funding totals exclude debt, grants and state aid; rounds whose instrument is not yet established are still counted. Every figure links to its source.

• Funding27 Jan 2025EUR 22.7M

  Atrandi Biosciences secured €22.7 million in funding, placing third in investment size in Lithuania.

  ▸Source: Startup Lithuania

  “The total value of Lithuania’s startup ecosystem reached €16.4 billion in 2025, according to the latest Dealroom report initiated by Startup Lithuania, a division of the Innovation Agency. In just…”

  Read at Startup Lithuania

• Juozas Nainys

  CEO & co-founder

• Karolis Leonavičius

  Chief Technology Officer

What does Atrandi Biosciences do?

Lithuanian life-sciences tools company commercialising patented Semi-Permeable Capsule (SPC) technology for single-cell genomics and multiomics.

When was Atrandi Biosciences founded?

Atrandi Biosciences was founded in 2016.

Where is Atrandi Biosciences headquartered?

Atrandi Biosciences is headquartered in Vilnius, Lithuania.

How much funding has Atrandi Biosciences raised?

Atrandi Biosciences has raised €22.7M (across 1 round · last 27 Jan 2025).

What was Atrandi Biosciences's latest funding round?

Atrandi Biosciences's most recent disclosed round was a funding round of €22.7M, announced 27 January 2025.